
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.00 | 100.00 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.76 | 29.60 |
Price to Book | 7.25 | 7.46 |
Price to Sales | 5.75 | 4.98 |
Price to Cash Flow | 19.27 | 19.07 |
Dividend Yield | 0.73 | 0.71 |
5 Years Earnings Growth | 12.00 | 13.22 |
Name | Net % | Category Average |
---|---|---|
Technology | 42.93 | 41.18 |
Financial Services | 15.59 | 9.51 |
Consumer Cyclical | 12.66 | 13.97 |
Healthcare | 10.31 | 9.75 |
Industrials | 6.33 | 7.13 |
Communication Services | 6.29 | 12.88 |
Real Estate | 3.36 | 1.38 |
Consumer Defensive | 2.53 | 3.40 |
Number of long holdings: 39
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 12.39 | 510.96 | -2.19% | |
NVIDIA | US67066G1040 | 9.50 | 183.16 | -4.89% | |
Amazon.com | US0231351067 | 7.98 | 216.37 | -4.99% | |
Apple | US0378331005 | 7.47 | 245.27 | -3.45% | |
Alphabet A | US02079K3059 | 5.99 | 236.57 | -2.05% | |
Visa A | US92826C8394 | 5.35 | 343.65 | -0.98% | |
ICE | US45866F1049 | 3.55 | 157.50 | -1.13% | |
UnitedHealth | US91324P1021 | 3.29 | 354.50 | -3.59% | |
Salesforce Inc | US79466L3024 | 2.71 | 241.68 | -1.49% | |
Waste Connections | CA94106B1013 | 2.67 | 172.85 | +1.56% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Ivy Large Cap Growth I | 4.33B | 8.63 | 25.18 | 16.52 | ||
Ivy Science & Technology A | 4.21B | 30.35 | 35.54 | 18.05 | ||
Ivy Large Cap Growth A | 3.15B | 8.42 | 24.85 | 16.19 | ||
Ivy Core Equity A | 2.83B | 15.09 | 24.51 | 14.48 | ||
Ivy Mid Cap Growth I | 1.59B | 4.94 | 11.13 | 11.75 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review